Daily Stock Analysis, CSII, Cardiovascular Systems Inc, priceseries

Cardiovascular Systems Inc. Daily Stock Analysis
Stock Information
Open
21.68
Close
21.13
High
21.98
Low
21.02
Previous Close
21.93
Daily Price Gain
-0.80
YTD High
22.13
YTD High Date
Mar 3, 2022
YTD Low
15.22
YTD Low Date
Feb 3, 2022
YTD Price Change
0.99
YTD Gain
4.92%
52 Week High
44.57
52 Week High Date
Jun 25, 2021
52 Week Low
15.22
52 Week Low Date
Feb 3, 2022
52 Week Price Change
-18.99
52 Week Gain
-47.33%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 30. 2019
30.06
Mar 15. 2019
39.88
31 Trading Days
32.66%
Link
LONG
Jan 6. 2020
48.81
Jan 24. 2020
51.60
13 Trading Days
5.72%
Link
LONG
Dec 14. 2020
37.67
Jan 4. 2021
42.11
13 Trading Days
11.79%
Link
LONG
Jun 15. 2021
40.05
Jun 30. 2021
42.66
11 Trading Days
6.51%
Link
Company Information
Stock Symbol
CSII
Exchange
NasdaqGS
Company URL
http://www.csi360.com
Company Phone
651-259-1600
CEO
Scott R. Ward
Headquarters
Minnesota
Business Address
1225 OLD HWY 8 NW, ST. PAUL, MN 55112
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001180145
About

Cardiovascular Systems, Inc. is a medical device company, which develops and sells devices for treating cardiovascular diseases. It focuses on developing and commercializing minimally invasive treatment solutions for vascular diseases. The company's products such as diamondback 360 ー PAD system and the stealth 360 ー PAD system are catheter based platforms capable of treating a broad range of plaque types in leg arteries both above and below the knee. The company was founded in 2000 and is headquartered in St. Paul, MN.

Description

Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Stealth 360 Peripheral OAS, Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, and Diamondback 360 2.00 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with other surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.